Responses
Epidemiology
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study
Compose a Response to This Article
Other responses
No responses have been published for this article.